Emerald Mutual Fund Advisers Trust Madrigal Pharmaceuticals, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.23 Billion
- Q1 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 35,238 shares of MDGL stock, worth $10 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
35,238
Previous 18,656
88.88%
Holding current value
$10 Million
Previous $5.76 Million
102.76%
% of portfolio
0.95%
Previous 0.4%
Shares
8 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$629 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$598 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$576 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$568 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$563 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.88B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...